[Evaluation of 4 antimicrobials in the treatment of typhoid fever caused by Salmonella typhi resistant to chloramphenicol].
D000293:Adolescent; D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D005664:Furazolidone / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D012485:Salmonella typhi / Q000187:drug effects*; D014295:Trimethoprim / Q000494:pharmacology; D014435:Typhoid Fever / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D005664:Furazolidone; D002701:Chloramphenicol; D000667:Ampicillin; D014295:Trimethoprim
Evaluación de cuatro antimicrobianos en el tratamiento de tifoidea por Salmonella typhi resistente a cloranfenicol